Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 25, 2023
Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacyKelly J Gaffney, James A Davis, Mary McGann, et al.
The Journal of Vascular Access|July 5, 2021
PICC line management among patients with chronic kidney diseaseBharvi P Oza-Gajera, James A Davis, Crystal Farrington, et al.
Plant Physiology|January 28, 2023
Overexpressing Vitamin C Defective 2 reduces fertility and alters Ca2+ signals in Arabidopsis pollenChrystle Weigand, Deborah Brady, James A Davis, et al.
Scientific Reports|January 14, 2022
Production of hydrogen peroxide in an intra-meander hyporheic zone at East River, ColoradoXiu Yuan, Tongxu Liu, Patricia Fox, et al.
Physiologia Plantarum|February 27, 2024
Deficiencies in cluster-2 ALA lipid flippases result in salicylic acid-dependent growth reductionsJames A Davis, Lisbeth R Poulsen, Bodil Kjeldgaard, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 18, 2025
Real-World Outcomes of Sequential BCMA-directed therapies in Relapsed Refractory Multiple Myeloma After Belantamab ExposurePrerna Mewawalla, Rachel Dileo, Yue Yin, et al.
Environmental Pollution (Barking, Essex : 1987)|May 25, 2016
Adsorption and desorption of arsenate on sandy sediments from contaminated and uncontaminated saturated zones: Kinetic and equilibrium modelingSaeedreza Hafeznezami, Amity G Zimmer-Faust, Aislinn Dunne, et al.
Transplantation and Cellular Therapy|February 22, 2023
Stem Cell Mobilization for Multiple Myeloma Patients Receiving Daratumumab-Based Induction Therapy: A Real- World ExperienceAswani Thurlapati, Kiera Roubal, James A Davis, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2022
Fever Characteristics and Impact on Safety and Efficacy of Chimeric Antigen Receptor T-Cell TherapyJames A Davis, Kelly J Gaffney, Mary McGann, et al.
Transplantation and Cellular Therapy|December 24, 2023
Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple MyelomaJames A Davis, Danai Dima, Nausheen Ahmed, et al.
Pageof 10